Investor Relations • Bioservo Technologies

Investor Relations

Five reasons to invest in Bioservo Technologies AB:

      1. Disruptor within the exoskeleton field – years ahead of competition
      2. Proven concept within healthcare, product on the market since 2013
      3. GM and NASA agreement backing Bioservo Technologies
        • Breakthrough for soft exoskeleton in industry application
        • Global customers: GM and Airbus
        • Massive interest from industry
      4. Unique technology and strong patent portfolio
        • 9 patents filed
      5. Fast growing market
        • Prevention of injuries & worker augmentation is a strong focus within industry
        • Challenging demographics – aging workforce
        • Target group: 50 million factory workers
        • Market for exoskeleton estimated to reach USD 1.9 billion in 2025